Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deepak L Bhatt

Showing results (251-260 of 2,280) with videos related to

Pageof 228
Sort By:
Journal of the American College of Cardiology|February 26, 2021
Crossover in COAPT: Does This Extend the Reach of TMVr for Treating Functional MR?Jeremiah P Depta, Deepak L Bhatt
Circulation|August 10, 2005
Does creatinine kinase-MB elevation after percutaneous coronary intervention predict outcomes in 2005? Periprocedural cardiac enzyme elevation predicts adverse outcomesDeepak L Bhatt, Eric J Topol
Cleveland Clinic Journal of Medicine|May 22, 2008
Interpreting the CHARISMA study. What is the role of dual antiplatelet therapy with clopidogrel and aspirin?Mihir R Bakhru, Deepak L Bhatt
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|April 22, 2008
Aspirin and platelet adenosine diphosphate receptor antagonists in acute coronary syndromes and percutaneous coronary intervention: role in therapy and strategies to overcome resistanceJeremiah P Depta, Deepak L Bhatt
Circulation. Cardiovascular Interventions|December 25, 2009
Should dual antiplatelet therapy after drug-eluting stents be continued for more than 1 year?: Dual antiplatelet therapy after drug-eluting stents should be continued for more than one year and preferably indefinitelyAdnan K Chhatriwalla, Deepak L Bhatt
The New England Journal of Medicine|December 22, 2018
Toward Precision Policy - The Case of Cardiovascular CareRishi K Wadhera, Deepak L Bhatt
Archives of Internal Medicine|October 24, 2002
The arterial inflammation hypothesisDeepak L Bhatt, Eric J Topol
Journal of Thrombosis and Thrombolysis|October 2, 2002
Antiplatelet therapies in combination for the treatment of patients with stable and unstable coronary artery diseaseRonnier J Aviles, Deepak L Bhatt
Circulation|July 3, 2002
Need to test the arterial inflammation hypothesisDeepak L Bhatt, Eric J Topol
Cardiology in Review|April 23, 2003
Highlights of the 2002 update to the 2000 American College of Cardiology/American Heart Association acute coronary syndrome guidelinesMichael S Chen, Deepak L Bhatt, , et al.
Pageof 228

Showing results (251-260 of 2,280) with videos related to

Sort By:
Pageof 228
Journal of the American College of Cardiology|February 26, 2021
Crossover in COAPT: Does This Extend the Reach of TMVr for Treating Functional MR?Jeremiah P Depta, Deepak L Bhatt
Circulation|August 10, 2005
Does creatinine kinase-MB elevation after percutaneous coronary intervention predict outcomes in 2005? Periprocedural cardiac enzyme elevation predicts adverse outcomesDeepak L Bhatt, Eric J Topol
Cleveland Clinic Journal of Medicine|May 22, 2008
Interpreting the CHARISMA study. What is the role of dual antiplatelet therapy with clopidogrel and aspirin?Mihir R Bakhru, Deepak L Bhatt
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|April 22, 2008
Aspirin and platelet adenosine diphosphate receptor antagonists in acute coronary syndromes and percutaneous coronary intervention: role in therapy and strategies to overcome resistanceJeremiah P Depta, Deepak L Bhatt
Circulation. Cardiovascular Interventions|December 25, 2009
Should dual antiplatelet therapy after drug-eluting stents be continued for more than 1 year?: Dual antiplatelet therapy after drug-eluting stents should be continued for more than one year and preferably indefinitelyAdnan K Chhatriwalla, Deepak L Bhatt
The New England Journal of Medicine|December 22, 2018
Toward Precision Policy - The Case of Cardiovascular CareRishi K Wadhera, Deepak L Bhatt
Archives of Internal Medicine|October 24, 2002
The arterial inflammation hypothesisDeepak L Bhatt, Eric J Topol
Journal of Thrombosis and Thrombolysis|October 2, 2002
Antiplatelet therapies in combination for the treatment of patients with stable and unstable coronary artery diseaseRonnier J Aviles, Deepak L Bhatt
Circulation|July 3, 2002
Need to test the arterial inflammation hypothesisDeepak L Bhatt, Eric J Topol
Cardiology in Review|April 23, 2003
Highlights of the 2002 update to the 2000 American College of Cardiology/American Heart Association acute coronary syndrome guidelinesMichael S Chen, Deepak L Bhatt, , et al.
Pageof 228